Cite
APA Citation
Léger, J., De Bleecker, J. L., Sommer, C., Robberecht, W., Saarela, M., Kamienowski, J., Stelmasiak, Z., Mielke, O., Tackenberg, B., Shebl, A., Bauhofer, A., Zenker, O., Merkies, I. S. J., & , (2013). efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single‐arm, open‐label Phase III study (the PRIMA study). Journal of the peripheral nervous system, 18(2), 130–140. http://access.bl.uk/ark:/81055/vdc_100024483535.0x00002f